Nearly every major medical breakthrough over the past 50 years can be attributed to new discoveries that were made possible through meticulous biomedical research. Many diseases and conditions that previously took a heavy toll on patients in terms of both morbidity and mortality are now either treatable or preventable thanks in large part to painstaking research that expanded the frontiers of scientific knowledge and moved the most promising basic research developments into tangible health benefits through human clinical trails. Ongoing research is also the key that will open the door to additional major medical advances and breakthroughs in the future.
Our staff at Medifocus is committed to keeping our subscribers to the Medifocus Digest Alert on Myelodysplastic Syndromes abreast of the latest new research developments that have recently been published in the medical literature for this condition. In this issue of the Digest Alert, you will find a focused list of hand-picked journal article references that represent the latest advances in basic and clinical research for Myelodysplastic Syndromes. These articles represent the current state-of-the-art of the research that will hopefully lead to additional major advances and breakthroughs in the clinical management of Myelodysplastic Syndromes. You can access the summaries of each article referenced below by simply clicking on the article Title.
We will continue to update you with the latest scientific and clinical developments through the Medifocus Digest Alert on Myelodysplastic Syndromes every 3 months. Thank you for your ongoing subscription to this publication.
Elliot Jacob, Ph.D.
Vice-President - Content
|Authors:||Wang C, Sallman DA|
|Institution:||Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.|
|Journal:||Cancer J. 2022 Jan-Feb 01;28(1):51-61. doi: 10.1097/PPO.0000000000000569.|
|Authors:||DeZern AE, Dalton WB|
|Institution:||Division of Hematologic Malignancies, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.|
|Journal:||Expert Rev Hematol. 2022 Jan;15(1):15-24. doi: 10.1080/17474086.2022.2029698. Epub 2022 Jan 24.|
|Authors:||Zeidan AM, DeAngelo DJ, Palmer J, Seet CS, Tallman MS, Wei X, Raymon H, Sriraman P, Kopytek S, Bewersdorf JP, Burgess MR, Hege K, Stock W|
|Institution:||Department of Internal Medicine, Yale University and Yale Cancer Center, New Haven, CT, USA. email@example.com. University of Chicago Medicine, Chicago, IL, USA.|
|Journal:||Ann Hematol. 2022 Mar;101(3):557-569. doi: 10.1007/s00277-021-04734-2. Epub 2022 Jan 4.|
|Authors:||Kaka S, Jahangirnia A, Beauregard N, Davis A, Tinmouth A, Chin-Yee N|
|Institution:||Faculty of Medicine, University of Ottawa/The Ottawa Hospital, Ottawa, Ontario, Canada. University of Toronto, Toronto, Ontario, Canada.|
|Journal:||Transfus Med. 2022 Feb;32(1):3-23. doi: 10.1111/tme.12841. Epub 2021 Dec 19.|
|Authors:||Aguirre LE, Komrokji R, Padron E|
|Institution:||H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. Electronic address: firstname.lastname@example.org.|
|Journal:||Best Pract Res Clin Haematol. 2021 Dec;34(4):101325. doi: 10.1016/j.beha.2021.101325. Epub 2021 Oct 23.|
|Institution:||UC San Diego Moores Cancer Center, 3855 Health Sciences Drive, San Diego, CA, 92093, USA. Electronic address: email@example.com.|
|Journal:||Best Pract Res Clin Haematol. 2021 Dec;34(4):101324. doi: 10.1016/j.beha.2021.101324. Epub 2021 Oct 23.|
|Authors:||Henry DH, Glaspy J, Harrup R, Mittelman M, Zhou A, Carraway HE, Bradley C, Saha G, Modelska K, Bartels P, Leong R, Yu KP|
|Institution:||Pennsylvania Hospital, University of Pennsylvania, Philadelphia, Pennsylvania, USA. FibroGen Inc, San Francisco, California, USA.|
|Journal:||Am J Hematol. 2022 Feb 1;97(2):174-184. doi: 10.1002/ajh.26397. Epub 2021 Nov 9.|
|Authors:||Zeidan AM, Salimi T, Epstein RS|
|Institution:||Section of Hematology, Department of Medicine, Yale School of Medicine & Yale Cancer Center, New Haven, CT 06511, USA. Epstein Health LLC, Woodcliff Lake, NJ 07677, USA.|
|Journal:||Future Oncol. 2021 Dec;17(36):5163-5175. doi: 10.2217/fon-2021-0936. Epub 2021 Oct 12.|
|Authors:||Duetz C, Cucchi DGJ, Polak TB, Janssen JJWM, Ossenkoppele GJ, Estey EH, van de Loosdrecht AA|
|Institution:||Department of Hematology, Amsterdam UMC, location VUmc, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands.|
|Journal:||Br J Haematol. 2022 Jan;196(2):329-335. doi: 10.1111/bjh.17892. Epub 2021 Oct 10.|
|Authors:||Kim N, Pavletic S, Norsworthy KJ|
|Institution:||National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.|
|Journal:||Br J Haematol. 2022 Mar;196(5):1137-1148. doi: 10.1111/bjh.17838. Epub 2021 Oct 10.|
|Authors:||Schwind S, Jentzsch M, Kubasch AS, Metzeler KH, Platzbecker U|
|Institution:||Medical Clinic and Policlinic 1, Hematology, Cellular Therapy and Hemostaseology, Leipzig University Hospital, Leipzig, Germany. Leipzig University Hospital, Leipzig, Germany. Leipzig University Hospital, Leipzig, Germany. Leipzig University Hospital, Leipzig, Germany. Leipzig University Hospital, Leipzig, Germany; German MDS Study Group (G-MDS), Leipzig, Germany; European Myelodysplastic Syndromes Cooperative Group, Leipzig, Germany. Electronic address: firstname.lastname@example.org.|
|Journal:||Neoplasia. 2021 Nov;23(11):1101-1109. doi: 10.1016/j.neo.2021.09.002. Epub 2021 Sep 30.|
|Authors:||Xu K, Hansen E|
|Institution:||VA Central Ohio Healthcare System, Columbus, USA.|
|Journal:||J Oncol Pharm Pract. 2021 Dec;27(8):1982-1992. doi: 10.1177/10781552211037993. Epub 2021 Sep 24.|
|Authors:||Stojkov I, Conrads-Frank A, Rochau U, Koinig KA, Arvandi M, Puntscher S, van Marrewijk C, Fenaux P, Symeonidis A, Chermat F, Garelius H, Bowen D, Mittelman M, Mora E, de Witte T, Efficace F, Siebert U, Stauder R|
|Institution:||Institute of Public Health, Medical Decision Making, and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics, and Technology, Hall in Tirol, Austria. Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University, Innsbruck, Austria.|
|Journal:||Blood Adv. 2022 Jan 11;6(1):1-12. doi: 10.1182/bloodadvances.2021004568.|
|Authors:||Pierri F, Faraci M, Giardino S, Dufour C|
|Institution:||Hematopoietic Stem Cell Transplantation Unit, Italy. Genova, Italy.|
|Journal:||Expert Rev Hematol. 2021 Oct;14(10):911-925. doi: 10.1080/17474086.2021.1977119. Epub 2021 Sep 15.|
|Authors:||Wouters HJCM, Conrads-Frank A, Koinig KA, Smith A, Yu G, de Witte T, Wolffenbuttel BHR, Huls G, Siebert U, Stauder R, van der Klauw MM|
|Institution:||Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. email@example.com. Groningen, 9700 RB, Groningen, The Netherlands. firstname.lastname@example.org. Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria. Innsbruck, Innsbruck, Austria. of York, York, UK. of York, York, UK. Netherlands. Groningen, 9700 RB, Groningen, The Netherlands. Groningen, Groningen, The Netherlands. Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria. Medicine, Innsbruck, Austria. Harvard T.H. Chan School of Public Health, Boston, MA, USA. Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Innsbruck, Innsbruck, Austria. Groningen, 9700 RB, Groningen, The Netherlands.|
|Journal:||Ann Hematol. 2021 Dec;100(12):2921-2932. doi: 10.1007/s00277-021-04654-1. Epub 2021 Sep 2.|
|Institution:||MDS Unit, Department of Experimental and Clinical Medicine, Hematology, AOU Careggi, University of Florence , Florence , Italy.|
|Journal:||Curr Opin Oncol. 2021 Nov 1;33(6):681-686. doi: 10.1097/CCO.0000000000000790.|
|Authors:||Nazha A, Komrokji R, Meggendorfer M, Jia X, Radakovich N, Shreve J, Hilton CB, Nagata Y, Hamilton BK, Mukherjee S, Al Ali N, Walter W, Hutter S, Padron E, Sallman D, Kuzmanovic T, Kerr C, Adema V, Steensma DP, Dezern A, Roboz G, Garcia-Manero G, Erba H, Haferlach C, Maciejewski JP, Haferlach T, Sekeres MA|
|Institution:||Leukemia Program, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH. Institute, Tampa, FL. Cleveland, OH. Cleveland, OH. Cleveland, OH. Cleveland, OH. Institute, Tampa, FL. Institute, Tampa, FL. Institute, Tampa, FL. Cleveland, OH. Cleveland, OH. Cleveland, OH. School, Boston, MA. Medical College, New York, NY. TX. Cleveland, OH.|
|Journal:||J Clin Oncol. 2021 Nov 20;39(33):3737-3746. doi: 10.1200/JCO.20.02810. Epub 2021 Aug 18.|
|Authors:||Wang H, Li Y, Zhou W, Wang R, Li Y, Yu L|
|Institution:||School of Medicine, Nankai University, Tianjin, China; Department of Hematology, Chinese PLA General Hospital, Beijing, China; Department of Hematology and Oncology, International Cancer Center, Shenzhen Key Laboratory of Precision Medicine for Hematological Malignancies, Shenzhen University General Hospital, Shenzhen University Clinical Medical Academy, Shenzhen University Health Science Center, Shenzhen, China. Electronic address: email@example.com.|
|Journal:||Leuk Res. 2021 Nov;110:106645. doi: 10.1016/j.leukres.2021.106645. Epub 2021 Jun 23.|
|Authors:||Komrokji R, Al Ali N, Padron E, Lancet J, Nazha A, Steensma D, DeZern A, Roboz G, Garcia-Manero G, Sekeres MA, Sallman D|
|Institution:||Malignant Hematology Department, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.|
|Journal:||Leuk Lymphoma. 2021 Nov;62(11):2762-2767. doi: 10.1080/10428194.2021.1938028. Epub 2021 Jun 11.|
|Authors:||Estey E, Hasserjian RP, Döhner H|
|Institution:||Division of Hematology, University of Washington, Seattle, WA. Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany.|
|Journal:||Blood. 2022 Jan 20;139(3):323-332. doi: 10.1182/blood.2021011304.|
|Authors:||Schwabkey Z, Al Ali N, Sallman D, Kuykendall A, Talati C, Sweet K, Lancet J, Padron E, Komrokji R|
|Institution:||Hematology Department, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.|
|Journal:||Hematology. 2021 Dec;26(1):393-397. doi: 10.1080/16078454.2021.1929692.|
|Authors:||Liu L, Jia M, Sun L, Tian W, Tang P, Jiang Z|
|Institution:||Department of Hematology, First Affiliated Hospital of Zhengzhou University, 1 Jianshe East Road, Zhengzhou, 450052, China. firstname.lastname@example.org. Jianshe East Road, Zhengzhou, 450052, China. Jianshe East Road, Zhengzhou, 450052, China. Jianshe East Road, Zhengzhou, 450052, China. Jianshe East Road, Zhengzhou, 450052, China. Jianshe East Road, Zhengzhou, 450052, China.|
|Journal:||Clin Exp Med. 2021 Nov;21(4):537-543. doi: 10.1007/s10238-021-00712-0. Epub 2021 Apr 17.|
|Authors:||Hong S, Rybicki L, Corrigan D, Hamilton BK, Sobecks R, Kalaycio M, Gerds AT, Dean RM, Hill BT, Pohlman B, Jagadeesh D, Anwer F, Majhail NS|
|Institution:||Blood and Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA. Clinic, Cleveland, OH, USA. Cleveland, OH, USA. Cleveland, OH, USA. Cleveland, OH, USA. Cleveland, OH, USA. Cleveland, OH, USA. Cleveland, OH, USA. Cleveland, OH, USA. Cleveland, OH, USA. Cleveland, OH, USA. Cleveland, OH, USA. Cleveland, OH, USA. Electronic address: email@example.com.|
|Journal:||Hematol Oncol Stem Cell Ther. 2021 Dec;14(4):318-326. doi: 10.1016/j.hemonc.2020.11.006. Epub 2020 Dec 5.|
For a FREE PREVIEW of the Medifocus Guidebook on Myelodysplastic Syndromes click here
To purchase a copy of the COMPLETE Medifocus Guidebook on Myelodysplastic Syndromes click here
To subscribe to additional FREE Medifocus Digest Alert on other disease/condition areas click here
| || |
|Get the Medifocus Guidebook on Myelodysplastic Syndromes...|
at a Special 20% Discount
Updated: January 3, 2022
This one of a kind Guidebook offers:
- Answers to your critical health questions including the latest treatments, clinical trials, and expert research.
- High Quality, Professional level information you can trust and understand culled from the latest peer-reviewed journals.
- Timely, up to date content with free guidebook updates for 1 year.
- A unique resource to find leading experts, institutions, and support organizations including contact information and hyperlinks.
- Over 130,000 Guidebooks Sold
- 100% Risk Free Money Back Guarantee
ORDER THE GUIDEBOOK
The Medifocus Guidebook on Myelodysplastic Syndromes is available in the following two convenient formats:PRINTED GUIDEBOOK
Soft-cover book that is available for immediate shipping via either U.S. Priority Mail or International AirMail (outside the U.S.).
- Regular List Price = $49.95
- Less 20% Discount = - $10.00
- Discounted Price = $39.95(excluding shipping & handling)
Available for immediate download as a PDF document.
- Regular List Price = $34.95
- Less 20% Discount = - $7.00
- Discounted Price = $27.95
Order by Phone
Call Toll Free in the U.S.
From Outside the U.S.1-301-649-9300
You can also receive a 20% discount when you order your Guidebook by phone.
To receive your 20% discount, simply mention the Discount Coupon Code below to the customer service representative taking your order.
Discount Coupon Code for
Coupon Expires: January 7, 2023
What Our Customers Are Saying...
"I purchased the MediFocus Guidebook on Myelodysplastic Syndromes to help my father understand the disease that he has. Doctors in France do not communicate very well the various treatment options neither do they tell you about the prognosis with enough clarity and confidence. We live in France and we believe there is no equivalent in Europe to the service you offer. We have read the Guidebook attentively and have learned a great deal about this condition. The wording is simple enough to be understandable even for non-native English speakers. It was money well spent!"
Saint Ismier, France
"Your MediFocus Guidebook on Myelodysplastic Syndromes has been a valuable companion in providing wise counsel to a beleaguered soul. Many times I was comforted by knowing that I could have my questions answered correctly and completely by using your Guidebook. I wouldn't be without it for anything. Thank you again and again."
"Your Medifocus Guidebook on Myelodysplastic Syndromes has been extremely valuable to me in understanding the complicated disease that afflicts me. It can be very depressing but to understand it intellectually can be very calming and heartening. Fear of the unknown is most devastating and your Guidebook provides the facts in an understandable way without 'watering-down' the science. Thank you for your outstanding publication."
Los Angeles, California
| || |